Jingyi Zhang

Liaoning Key Lab Of Targeting Drugs For Hematological Malignancies
Shenyang, 110016, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Ethacrynic Oxadiazole 6u Induces Apoptosis by Targeting mTOR/c-Flip Axis and Noxa in Lymphoma Cells.

Ethacrynic Oxadiazole 6u Induces Apoptosis by Targeting mTOR/c-Flip Axis and Noxa in Lymphoma Cells.

Journal: Biological procedures online
Published: May 13, 2026

Optimization of 4-Aniline Substituted Pyrido[3,2-d]pyrimidine Derivatives as Pim/Mnk Dual Inhibitors with Antileukemia Activity.

Optimization of 4-Aniline Substituted Pyrido[3,2-d]pyrimidine Derivatives as Pim/Mnk Dual Inhibitors with Antileukemia Activity.

Journal: Journal of medicinal chemistry
Published: March 24, 2026

Discovery of a Novel Phenyl Thiophene-3-carboxamide Derivative DZX19 as an Orally TRK Inhibitor with Potent Antitumor Effects.

Discovery of a Novel Phenyl Thiophene-3-carboxamide Derivative DZX19 as an Orally TRK Inhibitor with Potent Antitumor Effects.

Journal: Journal of medicinal chemistry
Published: February 25, 2026

Suaeda salsa SsDHN Gene Enhances Drought Tolerance in Tobacco (Nicotiana tabacum).

Suaeda salsa SsDHN Gene Enhances Drought Tolerance in Tobacco (Nicotiana tabacum).

Journal: Plants (Basel, Switzerland)
Published: December 12, 2025

Treatment and survival outcomes for patients with follicular lymphoma and POD24: a systematic review and meta-analysis.

Treatment and survival outcomes for patients with follicular lymphoma and POD24: a systematic review and meta-analysis.

Journal: Blood advances
Published: September 29, 2025

CD20×CD3 bispecific antibody achieved significant efficacy in patients with large B-cell lymphoma relapsing after or refractory to CAR-T therapy: a systematic review and meta-analysis.

CD20×CD3 bispecific antibody achieved significant efficacy in patients with large B-cell lymphoma relapsing after or refractory to CAR-T therapy: a systematic review and meta-analysis.

Journal: Frontiers in oncology
Published: June 05, 2025

Site-specific engineering of S-Te-S bridged nano-prodrug: A dual equilibrium strategy for enhanced antitumor efficacy and safety of paclitaxel.

Site-specific engineering of S-Te-S bridged nano-prodrug: A dual equilibrium strategy for enhanced antitumor efficacy and safety of paclitaxel.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 04, 2025

Overcoming venetoclax resistance through heme-mediated NOXA/cyclin D1/Mcl-1 axis with a novel artemisinin conjugate.

Overcoming venetoclax resistance through heme-mediated NOXA/cyclin D1/Mcl-1 axis with a novel artemisinin conjugate.

Journal: Blood advances
Published: January 03, 2025

A statistical method for high-throughput emergence rate calculation for soybean breeding plots based on field phenotypic characteristics.

A statistical method for high-throughput emergence rate calculation for soybean breeding plots based on field phenotypic characteristics.

Journal: Plant methods
Published: November 18, 2024

Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1H-indole-1-yl Moiety Binding to the P1-P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells.

Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1H-indole-1-yl Moiety Binding to the P1-P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells.

Journal: Journal of medicinal chemistry
Published: August 09, 2024

Development of a series of novel Mcl-1 inhibitors bearing an indole carboxylic acid moiety.

Development of a series of novel Mcl-1 inhibitors bearing an indole carboxylic acid moiety.

Journal: Bioorganic chemistry
Published: March 30, 2022

Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis.

Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis.

Journal: Cell death & disease
Published: September 10, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026